 | • レポートコード：MRC2-11QY02284 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はαガラクトシダーゼAのグローバル市場について調査・分析したレポートです。種類別（アガルシダーゼアルファ、AVRRD-01、塩酸ミガラスタット、MOSS-AGAL、その他）市場規模、用途別（病院、クリニック、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別αガラクトシダーゼAの競争状況、市場シェア ・世界のαガラクトシダーゼA市場：種類別市場規模 2015年-2020年（アガルシダーゼアルファ、AVRRD-01、塩酸ミガラスタット、MOSS-AGAL、その他） ・世界のαガラクトシダーゼA市場：種類別市場規模予測 2021年-2026年（アガルシダーゼアルファ、AVRRD-01、塩酸ミガラスタット、MOSS-AGAL、その他） ・世界のαガラクトシダーゼA市場：用途別市場規模 2015年-2020年（病院、クリニック、在宅ケア） ・世界のαガラクトシダーゼA市場：用途別市場規模予測 2021年-2026年（病院、クリニック、在宅ケア） ・北米のαガラクトシダーゼA市場分析：米国、カナダ ・ヨーロッパのαガラクトシダーゼA市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのαガラクトシダーゼA市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のαガラクトシダーゼA市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのαガラクトシダーゼA市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amicus Therapeutics, Inc.、Greenovation Biotech GmbH、iBio, Inc.、ISU ABXIS Co.,Ltd.、JCR Pharmaceuticals Co., Ltd.、Pharming Group N.V.、Protalix BioTherapeutics, Inc.、Takeda ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Alpha Galactosidase A Market
The global Alpha Galactosidase A market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Alpha Galactosidase A Scope and Market Size
Alpha Galactosidase A market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alpha Galactosidase A market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Alpha Galactosidase A market is segmented into
Agalsidase Alfa
AVRRD-01
Migalastat Hydrochloride
MOSS-AGAL
Others
Segment by Application, the Alpha Galactosidase A market is segmented into
Hospital
Clinic
Home Care
Regional and Country-level Analysis
The Alpha Galactosidase A market is analysed and market size information is provided by regions (countries).
The key regions covered in the Alpha Galactosidase A market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Alpha Galactosidase A Market Share Analysis
Alpha Galactosidase A market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Alpha Galactosidase A business, the date to enter into the Alpha Galactosidase A market, Alpha Galactosidase A product introduction, recent developments, etc.
The major vendors covered:
Amicus Therapeutics, Inc.
Greenovation Biotech GmbH
iBio, Inc.
ISU ABXIS Co.,Ltd.
JCR Pharmaceuticals Co., Ltd.
Pharming Group N.V.
Protalix BioTherapeutics, Inc.
Takeda
1 Study Coverage
1.1 Alpha Galactosidase A Product Introduction
1.2 Market Segments
1.3 Key Alpha Galactosidase A Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Alpha Galactosidase A Market Size Growth Rate by Type
1.4.2 Agalsidase Alfa
1.4.3 AVRRD-01
1.4.4 Migalastat Hydrochloride
1.4.5 MOSS-AGAL
1.4.6 Others
1.5 Market by Application
1.5.1 Global Alpha Galactosidase A Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Care
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Alpha Galactosidase A Market Size, Estimates and Forecasts
2.1.1 Global Alpha Galactosidase A Revenue 2015-2026
2.1.2 Global Alpha Galactosidase A Sales 2015-2026
2.2 Global Alpha Galactosidase A, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Alpha Galactosidase A Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Alpha Galactosidase A Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Alpha Galactosidase A Competitor Landscape by Players
3.1 Alpha Galactosidase A Sales by Manufacturers
3.1.1 Alpha Galactosidase A Sales by Manufacturers (2015-2020)
3.1.2 Alpha Galactosidase A Sales Market Share by Manufacturers (2015-2020)
3.2 Alpha Galactosidase A Revenue by Manufacturers
3.2.1 Alpha Galactosidase A Revenue by Manufacturers (2015-2020)
3.2.2 Alpha Galactosidase A Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Alpha Galactosidase A Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Alpha Galactosidase A Revenue in 2019
3.2.5 Global Alpha Galactosidase A Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Alpha Galactosidase A Price by Manufacturers
3.4 Alpha Galactosidase A Manufacturing Base Distribution, Product Types
3.4.1 Alpha Galactosidase A Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Alpha Galactosidase A Product Type
3.4.3 Date of International Manufacturers Enter into Alpha Galactosidase A Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Alpha Galactosidase A Market Size by Type (2015-2020)
4.1.1 Global Alpha Galactosidase A Sales by Type (2015-2020)
4.1.2 Global Alpha Galactosidase A Revenue by Type (2015-2020)
4.1.3 Alpha Galactosidase A Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Alpha Galactosidase A Market Size Forecast by Type (2021-2026)
4.2.1 Global Alpha Galactosidase A Sales Forecast by Type (2021-2026)
4.2.2 Global Alpha Galactosidase A Revenue Forecast by Type (2021-2026)
4.2.3 Alpha Galactosidase A Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Alpha Galactosidase A Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Alpha Galactosidase A Market Size by Application (2015-2020)
5.1.1 Global Alpha Galactosidase A Sales by Application (2015-2020)
5.1.2 Global Alpha Galactosidase A Revenue by Application (2015-2020)
5.1.3 Alpha Galactosidase A Price by Application (2015-2020)
5.2 Alpha Galactosidase A Market Size Forecast by Application (2021-2026)
5.2.1 Global Alpha Galactosidase A Sales Forecast by Application (2021-2026)
5.2.2 Global Alpha Galactosidase A Revenue Forecast by Application (2021-2026)
5.2.3 Global Alpha Galactosidase A Price Forecast by Application (2021-2026)
6 North America
6.1 North America Alpha Galactosidase A by Country
6.1.1 North America Alpha Galactosidase A Sales by Country
6.1.2 North America Alpha Galactosidase A Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Alpha Galactosidase A Market Facts & Figures by Type
6.3 North America Alpha Galactosidase A Market Facts & Figures by Application
7 Europe
7.1 Europe Alpha Galactosidase A by Country
7.1.1 Europe Alpha Galactosidase A Sales by Country
7.1.2 Europe Alpha Galactosidase A Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Alpha Galactosidase A Market Facts & Figures by Type
7.3 Europe Alpha Galactosidase A Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Alpha Galactosidase A by Region
8.1.1 Asia Pacific Alpha Galactosidase A Sales by Region
8.1.2 Asia Pacific Alpha Galactosidase A Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Alpha Galactosidase A Market Facts & Figures by Type
8.3 Asia Pacific Alpha Galactosidase A Market Facts & Figures by Application
9 Latin America
9.1 Latin America Alpha Galactosidase A by Country
9.1.1 Latin America Alpha Galactosidase A Sales by Country
9.1.2 Latin America Alpha Galactosidase A Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Alpha Galactosidase A Market Facts & Figures by Type
9.3 Central & South America Alpha Galactosidase A Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Alpha Galactosidase A by Country
10.1.1 Middle East and Africa Alpha Galactosidase A Sales by Country
10.1.2 Middle East and Africa Alpha Galactosidase A Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Alpha Galactosidase A Market Facts & Figures by Type
10.3 Middle East and Africa Alpha Galactosidase A Market Facts & Figures by Application
11 Company Profiles
11.1 Amicus Therapeutics, Inc.
11.1.1 Amicus Therapeutics, Inc. Corporation Information
11.1.2 Amicus Therapeutics, Inc. Description and Business Overview
11.1.3 Amicus Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amicus Therapeutics, Inc. Alpha Galactosidase A Products Offered
11.1.5 Amicus Therapeutics, Inc. Related Developments
11.2 Greenovation Biotech GmbH
11.2.1 Greenovation Biotech GmbH Corporation Information
11.2.2 Greenovation Biotech GmbH Description and Business Overview
11.2.3 Greenovation Biotech GmbH Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Greenovation Biotech GmbH Alpha Galactosidase A Products Offered
11.2.5 Greenovation Biotech GmbH Related Developments
11.3 iBio, Inc.
11.3.1 iBio, Inc. Corporation Information
11.3.2 iBio, Inc. Description and Business Overview
11.3.3 iBio, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 iBio, Inc. Alpha Galactosidase A Products Offered
11.3.5 iBio, Inc. Related Developments
11.4 ISU ABXIS Co.,Ltd.
11.4.1 ISU ABXIS Co.,Ltd. Corporation Information
11.4.2 ISU ABXIS Co.,Ltd. Description and Business Overview
11.4.3 ISU ABXIS Co.,Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 ISU ABXIS Co.,Ltd. Alpha Galactosidase A Products Offered
11.4.5 ISU ABXIS Co.,Ltd. Related Developments
11.5 JCR Pharmaceuticals Co., Ltd.
11.5.1 JCR Pharmaceuticals Co., Ltd. Corporation Information
11.5.2 JCR Pharmaceuticals Co., Ltd. Description and Business Overview
11.5.3 JCR Pharmaceuticals Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Products Offered
11.5.5 JCR Pharmaceuticals Co., Ltd. Related Developments
11.6 Pharming Group N.V.
11.6.1 Pharming Group N.V. Corporation Information
11.6.2 Pharming Group N.V. Description and Business Overview
11.6.3 Pharming Group N.V. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pharming Group N.V. Alpha Galactosidase A Products Offered
11.6.5 Pharming Group N.V. Related Developments
11.7 Protalix BioTherapeutics, Inc.
11.7.1 Protalix BioTherapeutics, Inc. Corporation Information
11.7.2 Protalix BioTherapeutics, Inc. Description and Business Overview
11.7.3 Protalix BioTherapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Protalix BioTherapeutics, Inc. Alpha Galactosidase A Products Offered
11.7.5 Protalix BioTherapeutics, Inc. Related Developments
11.8 Takeda
11.8.1 Takeda Corporation Information
11.8.2 Takeda Description and Business Overview
11.8.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Takeda Alpha Galactosidase A Products Offered
11.8.5 Takeda Related Developments
11.1 Amicus Therapeutics, Inc.
11.1.1 Amicus Therapeutics, Inc. Corporation Information
11.1.2 Amicus Therapeutics, Inc. Description and Business Overview
11.1.3 Amicus Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amicus Therapeutics, Inc. Alpha Galactosidase A Products Offered
11.1.5 Amicus Therapeutics, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Alpha Galactosidase A Market Estimates and Projections by Region
12.1.1 Global Alpha Galactosidase A Sales Forecast by Regions 2021-2026
12.1.2 Global Alpha Galactosidase A Revenue Forecast by Regions 2021-2026
12.2 North America Alpha Galactosidase A Market Size Forecast (2021-2026)
12.2.1 North America: Alpha Galactosidase A Sales Forecast (2021-2026)
12.2.2 North America: Alpha Galactosidase A Revenue Forecast (2021-2026)
12.2.3 North America: Alpha Galactosidase A Market Size Forecast by Country (2021-2026)
12.3 Europe Alpha Galactosidase A Market Size Forecast (2021-2026)
12.3.1 Europe: Alpha Galactosidase A Sales Forecast (2021-2026)
12.3.2 Europe: Alpha Galactosidase A Revenue Forecast (2021-2026)
12.3.3 Europe: Alpha Galactosidase A Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Alpha Galactosidase A Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Alpha Galactosidase A Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Alpha Galactosidase A Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Alpha Galactosidase A Market Size Forecast by Region (2021-2026)
12.5 Latin America Alpha Galactosidase A Market Size Forecast (2021-2026)
12.5.1 Latin America: Alpha Galactosidase A Sales Forecast (2021-2026)
12.5.2 Latin America: Alpha Galactosidase A Revenue Forecast (2021-2026)
12.5.3 Latin America: Alpha Galactosidase A Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Alpha Galactosidase A Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Alpha Galactosidase A Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Alpha Galactosidase A Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Alpha Galactosidase A Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Alpha Galactosidase A Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Alpha Galactosidase A Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Alpha Galactosidase A Market Segments
Table 2. Ranking of Global Top Alpha Galactosidase A Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Alpha Galactosidase A Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Agalsidase Alfa
Table 5. Major Manufacturers of AVRRD-01
Table 6. Major Manufacturers of Migalastat Hydrochloride
Table 7. Major Manufacturers of MOSS-AGAL
Table 8. Major Manufacturers of Others
Table 9. Global Alpha Galactosidase A Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Alpha Galactosidase A Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Alpha Galactosidase A Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Alpha Galactosidase A Sales Market Share by Regions (2015-2020)
Table 13. Global Alpha Galactosidase A Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Alpha Galactosidase A Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Alpha Galactosidase A Sales Share by Manufacturers (2015-2020)
Table 16. Global Alpha Galactosidase A Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Alpha Galactosidase A by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha Galactosidase A as of 2019)
Table 18. Alpha Galactosidase A Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Alpha Galactosidase A Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Alpha Galactosidase A Price (2015-2020) (USD/Pcs)
Table 21. Alpha Galactosidase A Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Alpha Galactosidase A Product Type
Table 23. Date of International Manufacturers Enter into Alpha Galactosidase A Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Alpha Galactosidase A Sales by Type (2015-2020) (K Pcs)
Table 26. Global Alpha Galactosidase A Sales Share by Type (2015-2020)
Table 27. Global Alpha Galactosidase A Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Alpha Galactosidase A Revenue Share by Type (2015-2020)
Table 29. Alpha Galactosidase A Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Alpha Galactosidase A Sales by Application (2015-2020) (K Pcs)
Table 31. Global Alpha Galactosidase A Sales Share by Application (2015-2020)
Table 32. North America Alpha Galactosidase A Sales by Country (2015-2020) (K Pcs)
Table 33. North America Alpha Galactosidase A Sales Market Share by Country (2015-2020)
Table 34. North America Alpha Galactosidase A Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Alpha Galactosidase A Revenue Market Share by Country (2015-2020)
Table 36. North America Alpha Galactosidase A Sales by Type (2015-2020) (K Pcs)
Table 37. North America Alpha Galactosidase A Sales Market Share by Type (2015-2020)
Table 38. North America Alpha Galactosidase A Sales by Application (2015-2020) (K Pcs)
Table 39. North America Alpha Galactosidase A Sales Market Share by Application (2015-2020)
Table 40. Europe Alpha Galactosidase A Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Alpha Galactosidase A Sales Market Share by Country (2015-2020)
Table 42. Europe Alpha Galactosidase A Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Alpha Galactosidase A Revenue Market Share by Country (2015-2020)
Table 44. Europe Alpha Galactosidase A Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Alpha Galactosidase A Sales Market Share by Type (2015-2020)
Table 46. Europe Alpha Galactosidase A Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Alpha Galactosidase A Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Alpha Galactosidase A Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Alpha Galactosidase A Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Alpha Galactosidase A Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Alpha Galactosidase A Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Alpha Galactosidase A Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Alpha Galactosidase A Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Alpha Galactosidase A Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Alpha Galactosidase A Sales Market Share by Application (2015-2020)
Table 56. Latin America Alpha Galactosidase A Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Alpha Galactosidase A Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Alpha Galactosidase A Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Alpha Galactosidase A Revenue Market Share by Country (2015-2020)
Table 60. Latin America Alpha Galactosidase A Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Alpha Galactosidase A Sales Market Share by Type (2015-2020)
Table 62. Latin America Alpha Galactosidase A Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Alpha Galactosidase A Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Alpha Galactosidase A Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Alpha Galactosidase A Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Alpha Galactosidase A Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Alpha Galactosidase A Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Alpha Galactosidase A Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Alpha Galactosidase A Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Alpha Galactosidase A Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Alpha Galactosidase A Sales Market Share by Application (2015-2020)
Table 72. Amicus Therapeutics, Inc. Corporation Information
Table 73. Amicus Therapeutics, Inc. Description and Major Businesses
Table 74. Amicus Therapeutics, Inc. Alpha Galactosidase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Amicus Therapeutics, Inc. Product
Table 76. Amicus Therapeutics, Inc. Recent Development
Table 77. Greenovation Biotech GmbH Corporation Information
Table 78. Greenovation Biotech GmbH Description and Major Businesses
Table 79. Greenovation Biotech GmbH Alpha Galactosidase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Greenovation Biotech GmbH Product
Table 81. Greenovation Biotech GmbH Recent Development
Table 82. iBio, Inc. Corporation Information
Table 83. iBio, Inc. Description and Major Businesses
Table 84. iBio, Inc. Alpha Galactosidase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. iBio, Inc. Product
Table 86. iBio, Inc. Recent Development
Table 87. ISU ABXIS Co.,Ltd. Corporation Information
Table 88. ISU ABXIS Co.,Ltd. Description and Major Businesses
Table 89. ISU ABXIS Co.,Ltd. Alpha Galactosidase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. ISU ABXIS Co.,Ltd. Product
Table 91. ISU ABXIS Co.,Ltd. Recent Development
Table 92. JCR Pharmaceuticals Co., Ltd. Corporation Information
Table 93. JCR Pharmaceuticals Co., Ltd. Description and Major Businesses
Table 94. JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. JCR Pharmaceuticals Co., Ltd. Product
Table 96. JCR Pharmaceuticals Co., Ltd. Recent Development
Table 97. Pharming Group N.V. Corporation Information
Table 98. Pharming Group N.V. Description and Major Businesses
Table 99. Pharming Group N.V. Alpha Galactosidase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Pharming Group N.V. Product
Table 101. Pharming Group N.V. Recent Development
Table 102. Protalix BioTherapeutics, Inc. Corporation Information
Table 103. Protalix BioTherapeutics, Inc. Description and Major Businesses
Table 104. Protalix BioTherapeutics, Inc. Alpha Galactosidase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Protalix BioTherapeutics, Inc. Product
Table 106. Protalix BioTherapeutics, Inc. Recent Development
Table 107. Takeda Corporation Information
Table 108. Takeda Description and Major Businesses
Table 109. Takeda Alpha Galactosidase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Takeda Product
Table 111. Takeda Recent Development
Table 112. Global Alpha Galactosidase A Sales Forecast by Regions (2021-2026) (K Pcs)
Table 113. Global Alpha Galactosidase A Sales Market Share Forecast by Regions (2021-2026)
Table 114. Global Alpha Galactosidase A Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 115. Global Alpha Galactosidase A Revenue Market Share Forecast by Regions (2021-2026)
Table 116. North America: Alpha Galactosidase A Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. North America: Alpha Galactosidase A Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Europe: Alpha Galactosidase A Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Europe: Alpha Galactosidase A Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Asia Pacific: Alpha Galactosidase A Sales Forecast by Region (2021-2026) (K Pcs)
Table 121. Asia Pacific: Alpha Galactosidase A Revenue Forecast by Region (2021-2026) (US$ Million)
Table 122. Latin America: Alpha Galactosidase A Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. Latin America: Alpha Galactosidase A Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Middle East and Africa: Alpha Galactosidase A Sales Forecast by Country (2021-2026) (K Pcs)
Table 125. Middle East and Africa: Alpha Galactosidase A Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 127. Key Challenges
Table 128. Market Risks
Table 129. Main Points Interviewed from Key Alpha Galactosidase A Players
Table 130. Alpha Galactosidase A Customers List
Table 131. Alpha Galactosidase A Distributors List
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Alpha Galactosidase A Product Picture
Figure 2. Global Alpha Galactosidase A Sales Market Share by Type in 2020 & 2026
Figure 3. Agalsidase Alfa Product Picture
Figure 4. AVRRD-01 Product Picture
Figure 5. Migalastat Hydrochloride Product Picture
Figure 6. MOSS-AGAL Product Picture
Figure 7. Others Product Picture
Figure 8. Global Alpha Galactosidase A Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Home Care
Figure 12. Alpha Galactosidase A Report Years Considered
Figure 13. Global Alpha Galactosidase A Market Size 2015-2026 (US$ Million)
Figure 14. Global Alpha Galactosidase A Sales 2015-2026 (K Pcs)
Figure 15. Global Alpha Galactosidase A Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Alpha Galactosidase A Sales Market Share by Region (2015-2020)
Figure 17. Global Alpha Galactosidase A Sales Market Share by Region in 2019
Figure 18. Global Alpha Galactosidase A Revenue Market Share by Region (2015-2020)
Figure 19. Global Alpha Galactosidase A Revenue Market Share by Region in 2019
Figure 20. Global Alpha Galactosidase A Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Alpha Galactosidase A Revenue in 2019
Figure 22. Alpha Galactosidase A Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Alpha Galactosidase A Sales Market Share by Type (2015-2020)
Figure 24. Global Alpha Galactosidase A Sales Market Share by Type in 2019
Figure 25. Global Alpha Galactosidase A Revenue Market Share by Type (2015-2020)
Figure 26. Global Alpha Galactosidase A Revenue Market Share by Type in 2019
Figure 27. Global Alpha Galactosidase A Market Share by Price Range (2015-2020)
Figure 28. Global Alpha Galactosidase A Sales Market Share by Application (2015-2020)
Figure 29. Global Alpha Galactosidase A Sales Market Share by Application in 2019
Figure 30. Global Alpha Galactosidase A Revenue Market Share by Application (2015-2020)
Figure 31. Global Alpha Galactosidase A Revenue Market Share by Application in 2019
Figure 32. North America Alpha Galactosidase A Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Alpha Galactosidase A Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Alpha Galactosidase A Sales Market Share by Country in 2019
Figure 35. North America Alpha Galactosidase A Revenue Market Share by Country in 2019
Figure 36. U.S. Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Alpha Galactosidase A Market Share by Type in 2019
Figure 41. North America Alpha Galactosidase A Market Share by Application in 2019
Figure 42. Europe Alpha Galactosidase A Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Alpha Galactosidase A Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Alpha Galactosidase A Sales Market Share by Country in 2019
Figure 45. Europe Alpha Galactosidase A Revenue Market Share by Country in 2019
Figure 46. Germany Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Alpha Galactosidase A Market Share by Type in 2019
Figure 57. Europe Alpha Galactosidase A Market Share by Application in 2019
Figure 58. Asia Pacific Alpha Galactosidase A Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Alpha Galactosidase A Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Alpha Galactosidase A Sales Market Share by Region in 2019
Figure 61. Asia Pacific Alpha Galactosidase A Revenue Market Share by Region in 2019
Figure 62. China Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Alpha Galactosidase A Market Share by Type in 2019
Figure 85. Asia Pacific Alpha Galactosidase A Market Share by Application in 2019
Figure 86. Latin America Alpha Galactosidase A Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Alpha Galactosidase A Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Alpha Galactosidase A Sales Market Share by Country in 2019
Figure 89. Latin America Alpha Galactosidase A Revenue Market Share by Country in 2019
Figure 90. Mexico Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Alpha Galactosidase A Market Share by Type in 2019
Figure 97. Latin America Alpha Galactosidase A Market Share by Application in 2019
Figure 98. Middle East and Africa Alpha Galactosidase A Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Alpha Galactosidase A Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Alpha Galactosidase A Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Alpha Galactosidase A Revenue Market Share by Country in 2019
Figure 102. Turkey Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Alpha Galactosidase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Alpha Galactosidase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Alpha Galactosidase A Market Share by Type in 2019
Figure 109. Middle East and Africa Alpha Galactosidase A Market Share by Application in 2019
Figure 110. North America Alpha Galactosidase A Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Alpha Galactosidase A Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Alpha Galactosidase A Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Alpha Galactosidase A Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Alpha Galactosidase A Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Alpha Galactosidase A Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Alpha Galactosidase A Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Alpha Galactosidase A Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Alpha Galactosidase A Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Alpha Galactosidase A Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
α放射体の世界市場（～2026年） Alpha emitters are the radioactive substances which decay after emitting the alpha particles. Alpha emitter radionuclide is considered to be a new approach to treat many cancer types. Alpha particles offers the definite tumor cell slaughter action causing the less damage to adjacent normal tissues t…- インターロイキン1アルファの世界市場（～2026年） Market Analysis and Insights: Global Interleukin 1 Alpha Market The global Interleukin 1 Alpha market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Interleukin 1 Alpha Scope and Market Size Interleukin 1 Alpha market is seg…
- リソソームα-グルコシダーゼの世界市場（～2026年） Market Analysis and Insights: Global Lysosomal Alpha Glucosidase Market The global Lysosomal Alpha Glucosidase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Lysosomal Alpha Glucosidase Scope and Market Size Lysosomal…
- α-N-アセチルグルコサミニダーゼの世界市場（～2026年） Market Analysis and Insights: Global Alpha N-Acetylglucosaminidase Market The global Alpha N-Acetylglucosaminidase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Alpha N-Acetylglucosaminidase Scope and Market Size Alp…
- αフェトプロテイン検査の世界市場（～2026年） Market Analysis and Insights: Global Alpha-Fetaprotein Testing Market The global Alpha-Fetaprotein Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Alpha-Fetaprotein Testing Scope and Market Size Alpha-Fetaprote…